DUBLIN--(BUSINESS WIRE)--The "Flow Cytometry Market By Component, By Technology, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.
The flow cytometry market was valued at $4,695.8 million in 2021, and is projected to reach $10,421.6 million by 2031, registering a CAGR of 8.3% from 2022 to 2031.
Flow cytometry is a biophysical, laser-based analytical technology that measures and analyzes several physical characteristics of cells or particles suspended in a fluid, when passed through a laser beam. Flow cytometry has various advantages over traditional analytical methods such as ELISA, which has the ability to deliver precise and accurate results and lesser time consumption at approximately the same prices.
Flow cytometry technology is widely used in various fields of academic and clinical research, and diagnosis of diseases such as cancer, HIV, and hematological malignancies. Rise in count of patients suffering from HIV and cancer and increase in use of flow cytometry in hospitals & diagnostic centers, which has created an impending need of flow cytometry in effective diagnosis and monitoring of diseases.
Major factors that drive growth of the flow cytometry market include technological advancements and high adoption in various research and diagnostic applications. In addition, advent of flow cytometry technology in novel research applications such as cytogenomics, proteomics, and marine biology further supplement the market growth.
Further, rise in incidences of diseases such as cancer and HIV are expected to boost adoption of flow cytometry technology across diagnostic application. However, factors such as high-cost associated with instruments and reagents, lack of awareness among potential end users, and limited availability of technical expertise are expected to hamper the market growth. Preference of flow cytometry in drug discovery & development and diagnostics is expected to provide numerous growth opportunities.
The flow cytometry market is segmented on the basis of component, technology, application, end user, and region. By component, the flow cytometry market is segmented into instruments, reagents & consumables, software and services. The instrument segment is further divided into platforms, replaceable components, and accessories. The platforms segment is further categorized into sorters and analyzers.
Filters, lasers, detectors, and others are considered as types of replaceable components. The reagents market is further divided into antibodies, dyes, beads, and others. On the basis of technology, the market is segmented into cell-based flow cytometry and bead-based flow cytometry. On the basis of application, it is segmented into academic & clinical applications and diagnostic applications.
Key Benefits
- This report provides a detailed quantitative analysis of the current flow cytometry market trends and forecast estimations from 2022 to 2031, which assists to identify the prevailing market opportunities.
- An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of factors that drive and restrain the growth of the flow cytometry market is provided.
- The projections in this report are made by analyzing the current trends and future market potential from 2022 to 2031, in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help in understanding competitive outlook of the market.
Key Market Segments
By Component
- Instruments
- Reagents and consumables
- Software
- Services
By Technology
- Cell based flow cytometry
- Bead based flow cytometry
By Application
- Academic and clinical applications
- Diagnostic applications
By End User
- Hospitals
- Medical schools and clinical testing labs
- Commercial organizations
- Academic institutions
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Agilent Technologies, Inc.
- Becton Dickinson and Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- DiaSorin S.p.A.
- Miltenyi Biotec, Inc.
- Sartorius AG
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/pw0yps
"flow" - Google News
December 12, 2022 at 05:56PM
https://ift.tt/SE42VLc
The Worldwide Flow Cytometry Industry is Expected to Reach $10.4 Billion by 2031 - ResearchAndMarkets.com - Business Wire
"flow" - Google News
https://ift.tt/8VGqzJf
https://ift.tt/CEAGay4
Bagikan Berita Ini
0 Response to "The Worldwide Flow Cytometry Industry is Expected to Reach $10.4 Billion by 2031 - ResearchAndMarkets.com - Business Wire"
Post a Comment